Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (14th March 2019)

Record Type:
Journal Article
Title:
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (14th March 2019)
Main Title:
Correction to: Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Authors:
Amin, Asim
Plimack, Elizabeth R.
Ernstoff, Marc S.
Lewis, Lionel D.
Bauer, Todd M.
McDermott, David F.
Carducci, Michael
Kollmannsberger, Christian
Rini, Brian I.
Heng, Daniel Y. C.
Knox, Jennifer
Voss, Martin H.
Spratlin, Jennifer
Berghorn, Elmer
Yang, Lingfeng
Hammers, Hans J.
Abstract:
Is Part Of:
Journal for immunotherapy of cancer. Volume 7:Issue 1(2019)
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Issue Display:
Volume 7, Issue 1 (2019)
Year:
2019
Volume:
7
Issue:
1
Issue Sort Value:
2019-0007-0001-0000
Page Start:
Page End:
Publication Date:
2019-03-14
Subjects:
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:
http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:
10.1186/s40425-019-0559-3 ↗
Languages:
English
ISSNs:
2051-1426
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
23945.xml